Anticholinergic	B:C0242896
premedication	O
to	O
prevent	O
bradycardia	O
in	O
combined	O
spinal	O
anesthesia	I:C0002928
and	O
dexmedetomidine	O
sedation	O
:	O
a	O
randomized	O
,	O
double	O
-	I:C0013072
blind	I:C0013072
,	O
placebo	O
-	O
controlled	O
study	O
.	O

Anticholinergic	O
premedication	B:C0033045
to	O
prevent	O
bradycardia	O
in	O
combined	O
spinal	O
anesthesia	I:C0002928
and	O
dexmedetomidine	O
sedation	O
:	O
a	O
randomized	O
,	O
double	O
-	I:C0013072
blind	I:C0013072
,	O
placebo	O
-	O
controlled	O
study	O
.	O

Anticholinergic	O
premedication	O
to	O
prevent	O
bradycardia	B:C0428977
in	O
combined	O
spinal	O
anesthesia	I:C0002928
and	O
dexmedetomidine	O
sedation	O
:	O
a	O
randomized	O
,	O
double	O
-	I:C0013072
blind	I:C0013072
,	O
placebo	O
-	O
controlled	O
study	O
.	O

Anticholinergic	O
premedication	O
to	O
prevent	O
bradycardia	O
in	O
combined	O
spinal	B:C0002928
anesthesia	I:C0002928
and	O
dexmedetomidine	O
sedation	O
:	O
a	O
randomized	O
,	O
double	O
-	I:C0013072
blind	I:C0013072
,	O
placebo	O
-	O
controlled	O
study	O
.	O

Anticholinergic	O
premedication	O
to	O
prevent	O
bradycardia	O
in	O
combined	O
spinal	O
anesthesia	I:C0002928
and	O
dexmedetomidine	B:C0113293
sedation	O
:	O
a	O
randomized	O
,	O
double	O
-	I:C0013072
blind	I:C0013072
,	O
placebo	O
-	O
controlled	O
study	O
.	O

Anticholinergic	O
premedication	O
to	O
prevent	O
bradycardia	O
in	O
combined	O
spinal	O
anesthesia	I:C0002928
and	O
dexmedetomidine	O
sedation	B:C0344106
:	O
a	O
randomized	O
,	O
double	O
-	I:C0013072
blind	I:C0013072
,	O
placebo	O
-	O
controlled	O
study	O
.	O

Anticholinergic	O
premedication	O
to	O
prevent	O
bradycardia	O
in	O
combined	O
spinal	O
anesthesia	I:C0002928
and	O
dexmedetomidine	O
sedation	O
:	O
a	O
randomized	B:C0206034
,	O
double	O
-	I:C0013072
blind	I:C0013072
,	O
placebo	O
-	O
controlled	O
study	O
.	O

Anticholinergic	O
premedication	O
to	O
prevent	O
bradycardia	O
in	O
combined	O
spinal	O
anesthesia	I:C0002928
and	O
dexmedetomidine	O
sedation	O
:	O
a	O
randomized	O
,	O
double	B:C0013072
-	I:C0013072
blind	I:C0013072
,	O
placebo	O
-	O
controlled	O
study	O
.	O

When	O
dexmedetomidine	B:C0113293
is	O
used	O
in	O
patients	O
undergoing	O
spinal	O
anesthesia	I:C0002928
,	O
high	O
incidence	O
of	O
bradycardia	O
in	O
response	O
to	O
parasympathetic	O
activation	O
is	O
reported	O
.	O

When	O
dexmedetomidine	O
is	O
used	O
in	O
patients	O
undergoing	O
spinal	B:C0002928
anesthesia	I:C0002928
,	O
high	O
incidence	O
of	O
bradycardia	O
in	O
response	O
to	O
parasympathetic	O
activation	O
is	O
reported	O
.	O

When	O
dexmedetomidine	O
is	O
used	O
in	O
patients	O
undergoing	O
spinal	O
anesthesia	I:C0002928
,	O
high	O
incidence	O
of	O
bradycardia	B:C0428977
in	O
response	O
to	O
parasympathetic	O
activation	O
is	O
reported	O
.	O

When	O
dexmedetomidine	O
is	O
used	O
in	O
patients	O
undergoing	O
spinal	O
anesthesia	I:C0002928
,	O
high	O
incidence	O
of	O
bradycardia	O
in	O
response	O
to	O
parasympathetic	B:C0030510
activation	O
is	O
reported	O
.	O

Therefore	O
,	O
we	O
aimed	O
to	O
evaluate	O
the	O
effectiveness	O
of	O
atropine	B:C0004259
premedication	O
for	O
preventing	O
the	O
incidence	O
of	O
bradycardia	O
and	O
the	O
hemodynamic	O
effect	I:C0019010
on	O
patients	O
undergoing	O
spinal	O
anesthesia	I:C0002928
with	O
sedation	O
by	O
dexmedetomidine	O
.	O

Therefore	O
,	O
we	O
aimed	O
to	O
evaluate	O
the	O
effectiveness	O
of	O
atropine	O
premedication	B:C0033045
for	O
preventing	O
the	O
incidence	O
of	O
bradycardia	O
and	O
the	O
hemodynamic	O
effect	I:C0019010
on	O
patients	O
undergoing	O
spinal	O
anesthesia	I:C0002928
with	O
sedation	O
by	O
dexmedetomidine	O
.	O

Therefore	O
,	O
we	O
aimed	O
to	O
evaluate	O
the	O
effectiveness	O
of	O
atropine	O
premedication	O
for	O
preventing	O
the	O
incidence	O
of	O
bradycardia	B:C0428977
and	O
the	O
hemodynamic	O
effect	I:C0019010
on	O
patients	O
undergoing	O
spinal	O
anesthesia	I:C0002928
with	O
sedation	O
by	O
dexmedetomidine	O
.	O

Therefore	O
,	O
we	O
aimed	O
to	O
evaluate	O
the	O
effectiveness	O
of	O
atropine	O
premedication	O
for	O
preventing	O
the	O
incidence	O
of	O
bradycardia	O
and	O
the	O
hemodynamic	B:C0019010
effect	I:C0019010
on	O
patients	O
undergoing	O
spinal	O
anesthesia	I:C0002928
with	O
sedation	O
by	O
dexmedetomidine	O
.	O

Therefore	O
,	O
we	O
aimed	O
to	O
evaluate	O
the	O
effectiveness	O
of	O
atropine	O
premedication	O
for	O
preventing	O
the	O
incidence	O
of	O
bradycardia	O
and	O
the	O
hemodynamic	O
effect	I:C0019010
on	O
patients	O
undergoing	O
spinal	B:C0002928
anesthesia	I:C0002928
with	O
sedation	O
by	O
dexmedetomidine	O
.	O

Therefore	O
,	O
we	O
aimed	O
to	O
evaluate	O
the	O
effectiveness	O
of	O
atropine	O
premedication	O
for	O
preventing	O
the	O
incidence	O
of	O
bradycardia	O
and	O
the	O
hemodynamic	O
effect	I:C0019010
on	O
patients	O
undergoing	O
spinal	O
anesthesia	I:C0002928
with	O
sedation	B:C0344106
by	O
dexmedetomidine	O
.	O

Therefore	O
,	O
we	O
aimed	O
to	O
evaluate	O
the	O
effectiveness	O
of	O
atropine	O
premedication	O
for	O
preventing	O
the	O
incidence	O
of	O
bradycardia	O
and	O
the	O
hemodynamic	O
effect	I:C0019010
on	O
patients	O
undergoing	O
spinal	O
anesthesia	I:C0002928
with	O
sedation	O
by	O
dexmedetomidine	B:C0113293
.	O

Randomized	B:C0206034
,	O
double	O
-	I:C0013072
blind	I:C0013072
,	O
placebo	O
-	O
controlled	O
study	O
.	O

Randomized	O
,	O
double	B:C0013072
-	I:C0013072
blind	I:C0013072
,	O
placebo	O
-	O
controlled	O
study	O
.	O

Operating	B:C0029064
room	I:C0029064
.	O

One	O
hundred	O
fourteen	O
patients	B:C0113293
(	O
age	O
range	O
,	O
2	O
-	O
65	O
years	O
;	O
American	O
Society	I:C0037459
of	I:C0037459
Anesthesiology	I:C0037459
class	I:C0037459
I	I:C0037459
-	I:C0037459
II	I:C0037459
)	O
participated	O
in	O
this	O
study	O
,	O
willing	O
to	O
be	O
sedated	O
and	O
to	O
undergo	O
spinal	O
anesthesia	I:C0002928
.	O

One	O
hundred	O
fourteen	O
patients	O
(	O
age	O
range	O
,	O
2	O
-	O
65	O
years	O
;	O
American	B:C0037459
Society	I:C0037459
of	I:C0037459
Anesthesiology	I:C0037459
class	I:C0037459
I	I:C0037459
-	I:C0037459
II	I:C0037459
)	O
participated	O
in	O
this	O
study	O
,	O
willing	O
to	O
be	O
sedated	O
and	O
to	O
undergo	O
spinal	O
anesthesia	I:C0002928
.	O

One	O
hundred	O
fourteen	O
patients	O
(	O
age	O
range	O
,	O
2	O
-	O
65	O
years	O
;	O
American	O
Society	I:C0037459
of	I:C0037459
Anesthesiology	I:C0037459
class	I:C0037459
I	I:C0037459
-	I:C0037459
II	I:C0037459
)	O
participated	O
in	O
this	O
study	B:C2603343
,	O
willing	O
to	O
be	O
sedated	O
and	O
to	O
undergo	O
spinal	O
anesthesia	I:C0002928
.	O

One	O
hundred	O
fourteen	O
patients	O
(	O
age	O
range	O
,	O
2	O
-	O
65	O
years	O
;	O
American	O
Society	I:C0037459
of	I:C0037459
Anesthesiology	I:C0037459
class	I:C0037459
I	I:C0037459
-	I:C0037459
II	I:C0037459
)	O
participated	O
in	O
this	O
study	O
,	O
willing	O
to	O
be	O
sedated	O
and	O
to	O
undergo	O
spinal	B:C0002928
anesthesia	I:C0002928
.	O

The	O
patients	B:C0113293
were	O
divided	O
into	O
2	O
groups	O
:	O
group	O
A	O
and	O
group	O
C.	O
After	O
performing	O
spinal	O
anesthesia	I:C0002928
,	O
dexmedetomidine	O
was	O
infused	O
at	O
a	O
loading	O
dose	O
of	O
0.6	O
μg/kg	O
for	O
10	O
minutes	O
,	O
followed	O
by	O
an	O
infusion	O
at	O
0.25	O
μg	O
/(	O
kg	O
h	O
)	O
.	O

The	O
patients	O
were	O
divided	O
into	O
2	O
groups	O
:	O
group	O
A	O
and	O
group	O
C.	O
After	O
performing	O
spinal	B:C0002928
anesthesia	I:C0002928
,	O
dexmedetomidine	O
was	O
infused	O
at	O
a	O
loading	O
dose	O
of	O
0.6	O
μg/kg	O
for	O
10	O
minutes	O
,	O
followed	O
by	O
an	O
infusion	O
at	O
0.25	O
μg	O
/(	O
kg	O
h	O
)	O
.	O

The	O
patients	O
were	O
divided	O
into	O
2	O
groups	O
:	O
group	O
A	O
and	O
group	O
C.	O
After	O
performing	O
spinal	O
anesthesia	I:C0002928
,	O
dexmedetomidine	B:C0113293
was	O
infused	O
at	O
a	O
loading	O
dose	O
of	O
0.6	O
μg/kg	O
for	O
10	O
minutes	O
,	O
followed	O
by	O
an	O
infusion	O
at	O
0.25	O
μg	O
/(	O
kg	O
h	O
)	O
.	O

The	O
patients	O
were	O
divided	O
into	O
2	O
groups	O
:	O
group	O
A	O
and	O
group	O
C.	O
After	O
performing	O
spinal	O
anesthesia	I:C0002928
,	O
dexmedetomidine	O
was	O
infused	B:C0574032
at	O
a	O
loading	O
dose	O
of	O
0.6	O
μg/kg	O
for	O
10	O
minutes	O
,	O
followed	O
by	O
an	O
infusion	O
at	O
0.25	O
μg	O
/(	O
kg	O
h	O
)	O
.	O

The	O
patients	O
were	O
divided	O
into	O
2	O
groups	O
:	O
group	O
A	O
and	O
group	O
C.	O
After	O
performing	O
spinal	O
anesthesia	I:C0002928
,	O
dexmedetomidine	O
was	O
infused	O
at	O
a	O
loading	O
dose	O
of	O
0.6	O
μg/kg	O
for	O
10	O
minutes	O
,	O
followed	O
by	O
an	O
infusion	B:C0574032
at	O
0.25	O
μg	O
/(	O
kg	O
h	O
)	O
.	O

Simultaneously	O
with	O
the	O
loading	O
dose	O
of	O
dexmedetomidine	B:C0113293
,	O
patients	O
in	O
group	O
A	O
received	O
an	O
intravenous	O
bolus	O
of	O
0.5	O
mg	O
atropine	O
,	O
whereas	O
patients	O
in	O
group	O
C	O
received	O
an	O
intravenous	O
normal	O
saline	O
bolus	O
.	O

Simultaneously	O
with	O
the	O
loading	O
dose	O
of	O
dexmedetomidine	O
,	O
patients	B:C0113293
in	O
group	O
A	O
received	O
an	O
intravenous	O
bolus	O
of	O
0.5	O
mg	O
atropine	O
,	O
whereas	O
patients	O
in	O
group	O
C	O
received	O
an	O
intravenous	O
normal	O
saline	O
bolus	O
.	O

Simultaneously	O
with	O
the	O
loading	O
dose	O
of	O
dexmedetomidine	O
,	O
patients	O
in	O
group	O
A	O
received	O
an	O
intravenous	O
bolus	O
of	O
0.5	O
mg	O
atropine	B:C0004259
,	O
whereas	O
patients	O
in	O
group	O
C	O
received	O
an	O
intravenous	O
normal	O
saline	O
bolus	O
.	O

Simultaneously	O
with	O
the	O
loading	O
dose	O
of	O
dexmedetomidine	O
,	O
patients	O
in	O
group	O
A	O
received	O
an	O
intravenous	O
bolus	O
of	O
0.5	O
mg	O
atropine	O
,	O
whereas	O
patients	B:C0113293
in	O
group	O
C	O
received	O
an	O
intravenous	O
normal	O
saline	O
bolus	O
.	O

Simultaneously	O
with	O
the	O
loading	O
dose	O
of	O
dexmedetomidine	O
,	O
patients	O
in	O
group	O
A	O
received	O
an	O
intravenous	O
bolus	O
of	O
0.5	O
mg	O
atropine	O
,	O
whereas	O
patients	O
in	O
group	O
C	O
received	O
an	O
intravenous	O
normal	O
saline	O
bolus	B:C1511237
.	O

Data	O
on	O
administration	B:C1533734
of	O
atropine	O
and	O
ephedrine	O
were	O
collected	O
.	O

Data	O
on	O
administration	O
of	O
atropine	B:C0004259
and	O
ephedrine	O
were	O
collected	O
.	O

Data	O
on	O
administration	O
of	O
atropine	O
and	O
ephedrine	B:C0014479
were	O
collected	O
.	O

Hemodynamic	B:C4281788
data	O
including	O
heart	O
rate	I:C0018810
,	O
systolic	O
blood	I:C0871470
pressure	I:C0871470
,	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
(	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
)	O
,	O
and	O
mean	O
blood	I:C0428886
pressure	I:C0428886
(	O
mean	O
blood	I:C0428886
pressure	I:C0428886
)	O
were	O
also	O
recorded	O
.	O

Hemodynamic	O
data	O
including	O
heart	B:C0018810
rate	I:C0018810
,	O
systolic	O
blood	I:C0871470
pressure	I:C0871470
,	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
(	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
)	O
,	O
and	O
mean	O
blood	I:C0428886
pressure	I:C0428886
(	O
mean	O
blood	I:C0428886
pressure	I:C0428886
)	O
were	O
also	O
recorded	O
.	O

Hemodynamic	O
data	O
including	O
heart	O
rate	I:C0018810
,	O
systolic	B:C0871470
blood	I:C0871470
pressure	I:C0871470
,	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
(	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
)	O
,	O
and	O
mean	O
blood	I:C0428886
pressure	I:C0428886
(	O
mean	O
blood	I:C0428886
pressure	I:C0428886
)	O
were	O
also	O
recorded	O
.	O

Hemodynamic	O
data	O
including	O
heart	O
rate	I:C0018810
,	O
systolic	O
blood	I:C0871470
pressure	I:C0871470
,	O
diastolic	B:C0428883
blood	I:C0428883
pressure	I:C0428883
(	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
)	O
,	O
and	O
mean	O
blood	I:C0428886
pressure	I:C0428886
(	O
mean	O
blood	I:C0428886
pressure	I:C0428886
)	O
were	O
also	O
recorded	O
.	O

Hemodynamic	O
data	O
including	O
heart	O
rate	I:C0018810
,	O
systolic	O
blood	I:C0871470
pressure	I:C0871470
,	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
(	O
diastolic	B:C0428883
blood	I:C0428883
pressure	I:C0428883
)	O
,	O
and	O
mean	O
blood	I:C0428886
pressure	I:C0428886
(	O
mean	O
blood	I:C0428886
pressure	I:C0428886
)	O
were	O
also	O
recorded	O
.	O

Hemodynamic	O
data	O
including	O
heart	O
rate	I:C0018810
,	O
systolic	O
blood	I:C0871470
pressure	I:C0871470
,	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
(	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
)	O
,	O
and	O
mean	B:C0428886
blood	I:C0428886
pressure	I:C0428886
(	O
mean	O
blood	I:C0428886
pressure	I:C0428886
)	O
were	O
also	O
recorded	O
.	O

Hemodynamic	O
data	O
including	O
heart	O
rate	I:C0018810
,	O
systolic	O
blood	I:C0871470
pressure	I:C0871470
,	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
(	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
)	O
,	O
and	O
mean	O
blood	I:C0428886
pressure	I:C0428886
(	O
mean	B:C0428886
blood	I:C0428886
pressure	I:C0428886
)	O
were	O
also	O
recorded	O
.	O

The	O
incidence	O
of	O
bradycardia	B:C0428977
requiring	O
atropine	O
treatment	O
was	O
significantly	O
higher	O
in	O
group	O
C	O
than	O
group	O
A	O
(	O
P=.035	O
)	O
.	O

The	O
incidence	O
of	O
bradycardia	O
requiring	O
atropine	B:C0004259
treatment	O
was	O
significantly	O
higher	O
in	O
group	O
C	O
than	O
group	O
A	O
(	O
P=.035	O
)	O
.	O

The	O
incidence	O
of	O
bradycardia	O
requiring	O
atropine	O
treatment	B:C0087111
was	O
significantly	O
higher	O
in	O
group	O
C	O
than	O
group	O
A	O
(	O
P=.035	O
)	O
.	O

However	O
,	O
the	O
incidence	O
of	O
hypotension	B:C0020649
needing	O
ephedrine	O
treatment	O
showed	O
no	O
significant	O
difference	O
between	O
the	O
2	O
groups	O
(	O
P=.7	O
)	O
.	O

However	O
,	O
the	O
incidence	O
of	O
hypotension	O
needing	O
ephedrine	B:C0014479
treatment	O
showed	O
no	O
significant	O
difference	O
between	O
the	O
2	O
groups	O
(	O
P=.7	O
)	O
.	O

However	O
,	O
the	O
incidence	O
of	O
hypotension	O
needing	O
ephedrine	O
treatment	B:C0087111
showed	O
no	O
significant	O
difference	O
between	O
the	O
2	O
groups	O
(	O
P=.7	O
)	O
.	O

Systolic	B:C0871470
blood	I:C0871470
pressure	I:C0871470
and	O
heart	O
rate	I:C0018810
showed	O
no	O
significant	O
differences	O
between	O
the	O
2	O
groups	O
(	O
P=.138	O
and	O
.464	O
,	O
respectively	O
)	O
.	O

Systolic	O
blood	I:C0871470
pressure	I:C0871470
and	O
heart	B:C0018810
rate	I:C0018810
showed	O
no	O
significant	O
differences	O
between	O
the	O
2	O
groups	O
(	O
P=.138	O
and	O
.464	O
,	O
respectively	O
)	O
.	O

However	O
,	O
group	O
A	O
showed	O
significant	O
increases	O
in	O
diastolic	B:C0428883
blood	I:C0428883
pressure	I:C0428883
and	O
mean	O
blood	I:C0428886
pressure	I:C0428886
,	O
and	O
group	O
C	O
did	O
not	O
(	O
P=.014	O
and	O
.008	O
,	O
respectively	O
)	O
.	O

However	O
,	O
group	O
A	O
showed	O
significant	O
increases	O
in	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
and	O
mean	B:C0428886
blood	I:C0428886
pressure	I:C0428886
,	O
and	O
group	O
C	O
did	O
not	O
(	O
P=.014	O
and	O
.008	O
,	O
respectively	O
)	O
.	O

Prophylactic	B:C0199176
atropine	O
reduces	O
the	O
incidence	O
of	O
bradycardia	O
in	O
patients	O
undergoing	O
spinal	O
anesthesia	I:C0002928
with	O
dexmedetomidine	O
sedation	O
.	O

Prophylactic	O
atropine	B:C0004259
reduces	O
the	O
incidence	O
of	O
bradycardia	O
in	O
patients	O
undergoing	O
spinal	O
anesthesia	I:C0002928
with	O
dexmedetomidine	O
sedation	O
.	O

Prophylactic	O
atropine	O
reduces	O
the	O
incidence	O
of	O
bradycardia	B:C0428977
in	O
patients	O
undergoing	O
spinal	O
anesthesia	I:C0002928
with	O
dexmedetomidine	O
sedation	O
.	O

Prophylactic	O
atropine	O
reduces	O
the	O
incidence	O
of	O
bradycardia	O
in	O
patients	B:C0113293
undergoing	O
spinal	O
anesthesia	I:C0002928
with	O
dexmedetomidine	O
sedation	O
.	O

Prophylactic	O
atropine	O
reduces	O
the	O
incidence	O
of	O
bradycardia	O
in	O
patients	O
undergoing	O
spinal	B:C0002928
anesthesia	I:C0002928
with	O
dexmedetomidine	O
sedation	O
.	O

Prophylactic	O
atropine	O
reduces	O
the	O
incidence	O
of	O
bradycardia	O
in	O
patients	O
undergoing	O
spinal	O
anesthesia	I:C0002928
with	O
dexmedetomidine	B:C0113293
sedation	O
.	O

Prophylactic	O
atropine	O
reduces	O
the	O
incidence	O
of	O
bradycardia	O
in	O
patients	O
undergoing	O
spinal	O
anesthesia	I:C0002928
with	O
dexmedetomidine	O
sedation	B:C0344106
.	O

However	O
,	O
diastolic	B:C0428883
blood	I:C0428883
pressure	I:C0428883
and	O
mean	O
blood	I:C0428886
pressure	I:C0428886
showed	O
significant	O
increases	O
in	O
patients	O
when	O
prophylactic	O
atropine	O
was	O
administrated	O
.	O

However	O
,	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
and	O
mean	B:C0428886
blood	I:C0428886
pressure	I:C0428886
showed	O
significant	O
increases	O
in	O
patients	O
when	O
prophylactic	O
atropine	O
was	O
administrated	O
.	O

However	O
,	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
and	O
mean	O
blood	I:C0428886
pressure	I:C0428886
showed	O
significant	O
increases	O
in	O
patients	B:C0113293
when	O
prophylactic	O
atropine	O
was	O
administrated	O
.	O

However	O
,	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
and	O
mean	O
blood	I:C0428886
pressure	I:C0428886
showed	O
significant	O
increases	O
in	O
patients	O
when	O
prophylactic	B:C0199176
atropine	O
was	O
administrated	O
.	O

However	O
,	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
and	O
mean	O
blood	I:C0428886
pressure	I:C0428886
showed	O
significant	O
increases	O
in	O
patients	O
when	O
prophylactic	O
atropine	B:C0004259
was	O
administrated	O
.	O

However	O
,	O
diastolic	O
blood	I:C0428883
pressure	I:C0428883
and	O
mean	O
blood	I:C0428886
pressure	I:C0428886
showed	O
significant	O
increases	O
in	O
patients	O
when	O
prophylactic	O
atropine	O
was	O
administrated	B:C1533734
.	O

Therefore	O
,	O
atropine	B:C0004259
premedication	O
should	O
be	O
administered	O
cautiously	O
.	O

Therefore	O
,	O
atropine	O
premedication	B:C0033045
should	O
be	O
administered	O
cautiously	O
.	O

Therefore	O
,	O
atropine	O
premedication	O
should	O
be	O
administered	B:C1533734
cautiously	O
.	O

